Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Int J Oncol
    June 2018
  1. HAN W, Cao F, Gao XJ, Wang HB, et al
    ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Int J Oncol. 2018 Jun 21. doi: 10.3892/ijo.2018.4450.
    >> Share

  2. NOWAK A, Dziegiel P
    Implications of nestin in breast cancer pathogenesis (Review).
    Int J Oncol. 2018 Jun 14. doi: 10.3892/ijo.2018.4441.
    >> Share

    Retrospective analysis of estrogen receptor 1 and Nacetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Int J Oncol. 2018 Jun 11. doi: 10.3892/ijo.2018.4436.
    >> Share

    May 2018
  4. CHENG CC, Shi LH, Wang XJ, Wang SX, et al
    Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Int J Oncol. 2018 May 8. doi: 10.3892/ijo.2018.4399.
    >> Share

  5. KIM JY, Kim JC, Lee JY, Park MJ, et al
    Oct4 suppresses IRinduced premature senescence in breast cancer cells through STAT3- and NFkappaB-mediated IL24 production.
    Int J Oncol. 2018 May 2. doi: 10.3892/ijo.2018.4391.
    >> Share

    April 2018
  6. TAN Y, Zhou G, Wang X, Chen W, et al
    USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
    Int J Oncol. 2018 Apr 30. doi: 10.3892/ijo.2018.4387.
    >> Share

  7. ZHAO Y, Onda K, Yuan B, Tanaka S, et al
    Arsenic disulfideinduced apoptosis and its potential mechanism in two and threedimensionally cultured human breast cancer MCF7 cells.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4357.
    >> Share

    March 2018
  8. ZHAO FQ, Misra Y, Li DB, Wadsworth MP, et al
    Differential expression of Oct3/4 in human breast cancer and normal tissues.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4341.
    >> Share

  9. XIONG DD, Chen H, He RQ, Lan AH, et al
    MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis.
    Int J Oncol. 2018 Mar 28. doi: 10.3892/ijo.2018.4339.
    >> Share

  10. COLIN C, Meyer M, Cerella C, Kleinclauss A, et al
    Biotinylation enhances the anticancer effects of 15dPGJ2 against breast cancer cells.
    Int J Oncol. 2018 Mar 28. doi: 10.3892/ijo.2018.4338.
    >> Share

  11. BUSCHMANN D, Gonzalez R, Kirchner B, Mazzone C, et al
    Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Int J Oncol. 2018 Mar 27. doi: 10.3892/ijo.2018.4336.
    >> Share

  12. LI Y, Zhang Y, Liu X, Wang M, et al
    Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Int J Oncol. 2018 Mar 23. doi: 10.3892/ijo.2018.4332.
    >> Share

  13. WU T, Song H, Xie D, Zhao B, et al
    Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4331.
    >> Share

  14. BEBEROK A, Wrzesniok D, Rok J, Rzepka Z, et al
    Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway.
    Int J Oncol. 2018 Mar 8. doi: 10.3892/ijo.2018.4310.
    >> Share

  15. DI D, Chen L, Guo Y, Wang L, et al
    BCSC-1 suppresses human breast cancer metastasis by inhibiting NF-kappaB signaling.
    Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4309.
    >> Share

  16. MIYAGAWA Y, Matsushita Y, Suzuki H, Komatsu M, et al
    Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4301.
    >> Share

    February 2018
  17. CASTELLANOS-ESPARZA YC, Wu S, Huang L, Buquet C, et al
    Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells.
    Int J Oncol. 2018 Feb 9. doi: 10.3892/ijo.2018.4272.
    >> Share

  18. MAXWELL T, Lee KS, Kim S, Nam KS, et al
    Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells.
    Int J Oncol. 2018 Feb 9. doi: 10.3892/ijo.2018.4271.
    >> Share

  19. HAN Y, Fan S, Qin T, Yang J, et al
    Role of autophagy in breast cancer and breast cancer stem cells (Review).
    Int J Oncol. 2018 Feb 8. doi: 10.3892/ijo.2018.4270.
    >> Share

  20. YEN MC, Huang YC, Kan JY, Kuo PL, et al
    S100B expression in breast cancer as a predictive marker for cancer metastasis.
    Int J Oncol. 2018;52:433-440.
    >> Share

  21. NOWAK A, Grzegrzolka J, Kmiecik A, Piotrowska A, et al
    Role of nestin expression in angiogenesis and breast cancer progression.
    Int J Oncol. 2018;52:527-535.
    >> Share

    January 2018
  22. PENG F, Li Q, Sun JY, Luo Y, et al
    PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Int J Oncol. 2018 Jan 30. doi: 10.3892/ijo.2018.4257.
    >> Share

  23. ZHONG R, Liang B, Xin R, Zhu X, et al
    Deoxycytidine kinase participates in the regulation of radiation-induced autophagy and apoptosis in breast cancer cells.
    Int J Oncol. 2018 Jan 22. doi: 10.3892/ijo.2018.4250.
    >> Share

  24. YOU KS, Yi YW, Kwak SJ, Seong YS, et al
    Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
    Int J Oncol. 2018 Jan 15. doi: 10.3892/ijo.2018.4244.
    >> Share

  25. ABSMAIER M, Napieralski R, Schuster T, Aubele M, et al
    PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
    Int J Oncol. 2018 Jan 8. doi: 10.3892/ijo.2018.4241.
    >> Share

  26. CHANG LC, Hsieh MT, Yang JS, Lu CC, et al
    Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study.
    Int J Oncol. 2018;52:67-76.
    >> Share

  27. WANG Y, Yu X, Song H, Feng D, et al
    The STAT-ROS cycle extends IFNinduced cancer cell apoptosis.
    Int J Oncol. 2018;52:305-313.
    >> Share

    November 2017
  28. ALONSO-GONZALEZ C, Menendez-Menendez J, Gonzalez-Gonzalez A, Gonzalez A, et al
    Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells.
    Int J Oncol. 2017 Nov 28. doi: 10.3892/ijo.2017.4213.
    >> Share

  29. SONNENBLICK A, Salgado R, Brohee S, Zahavi T, et al
    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
    Int J Oncol. 2017 Nov 27. doi: 10.3892/ijo.2017.4212.
    >> Share

    October 2017
  30. RAMAN V, Fuentes Lorenzo JL, Stashenko EE, Levy M, et al
    Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-kappaB signaling in triple-negative breast cancer cells.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4169.
    >> Share

  31. BORAH N, Gunawardana S, Torres H, McDonnell S, et al
    5,6,7,3',4',5'-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle.
    Int J Oncol. 2017 Oct 13. doi: 10.3892/ijo.2017.4157.
    >> Share

  32. RATAJCZAK-WIELGOMAS K, Grzegrzolka J, Piotrowska A, Matkowski R, et al
    Expression of periostin in breast cancer cells.
    Int J Oncol. 2017;51:1300-1310.
    >> Share

  33. YIN H, Zhu Q, Liu M, Tu G, et al
    GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis.
    Int J Oncol. 2017;51:1191-1198.
    >> Share

  34. PHILLIPS SL, Williams CB, Zambrano JN, Williams CJ, et al
    Connexin 43 in the development and progression of breast cancer: What's the connection? (Review).
    Int J Oncol. 2017;51:1005-1013.
    >> Share

    September 2017
  35. YANG L, Li Y, Shen E, Cao F, et al
    NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
    Int J Oncol. 2017 Sep 21. doi: 10.3892/ijo.2017.4130.
    >> Share

  36. ESPINOZA-SANCHEZ NA, Vadillo E, Balandran JC, Monroy-Garcia A, et al
    Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
    Int J Oncol. 2017 Sep 19. doi: 10.3892/ijo.2017.4128.
    >> Share

  37. CALAF GM, Roy D
    Metastatic genes targeted by an antioxidant in an established radiation- and estrogen-breast cancer model.
    Int J Oncol. 2017 Sep 14. doi: 10.3892/ijo.2017.4125.
    >> Share

  38. D'ANGELO S, Martino E, Ilisso CP, Bagarolo ML, et al
    Pro-oxidant and pro-apoptotic activity of polyphenol extract from Annurca apple and its underlying mechanisms in human breast cancer cells.
    Int J Oncol. 2017;51:939-948.
    >> Share

  39. OBAYASHI S, Horiguchi J, Higuchi T, Katayama A, et al
    Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Int J Oncol. 2017;51:781-790.
    >> Share

  40. [Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.
    Int J Oncol. 2017;51:997-0.
    >> Share

    August 2017
  41. ILKOVICOVA L, Trost N, Szentpeteriova E, Solar P, et al
    Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen.
    Int J Oncol. 2017;51:737-746.
    >> Share

    July 2017
  42. WANG Y, Wang H, Ding Y, Li Y, et al
    N-peptide of vMIP- reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
    Int J Oncol. 2017 Jul 19. doi: 10.3892/ijo.2017.4076.
    >> Share

  43. LI SJ, Liu CS, Li HJ, Li Y, et al
    A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy.
    Int J Oncol. 2017 Jul 3. doi: 10.3892/ijo.2017.4062.
    >> Share

    June 2017
  44. KIM DH, Sung B, Kim JA, Kang YJ, et al
    HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4058.
    >> Share

  45. NOWAK A, Grzegrzolka J, Paprocka M, Piotrowska A, et al
    Nestin-positive microvessel density is an independent prognostic factor in breast cancer.
    Int J Oncol. 2017 Jun 26. doi: 10.3892/ijo.2017.4057.
    >> Share

  46. YAO M, Yuan B, Wang X, Sato A, et al
    Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
    Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4052.
    >> Share

    May 2017
  47. LIANG N, Li Y, Chung HY
    Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4004.
    >> Share

  48. LINDSTEN T, Hedbrant A, Ramberg A, Wijkander J, et al
    Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3996.
    >> Share

  49. DING Y, Zhang C, Zhang J, Zhang N, et al
    miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression.
    Int J Oncol. 2017;50:1701-1710.
    >> Share

  50. NGUYEN CH, Huttary N, Atanasov AG, Chatuphonprasert W, et al
    Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
    Int J Oncol. 2017;50:1879-1888.
    >> Share

    April 2017
  51. MCDERMOTT MSJ, Canonici A, Ivers L, Browne BC, et al
    Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells.
    Int J Oncol. 2017 Apr 26. doi: 10.3892/ijo.2017.3976.
    >> Share

    March 2017
  52. XI J, Feng J, Li Q, Li X, et al
    The long non-coding RNA lncFOXO1 suppresses growth of human breast cancer cells through association with BAP1.
    Int J Oncol. 2017 Mar 24. doi: 10.3892/ijo.2017.3933.
    >> Share

  53. OKAMOTO K, Tanaka Y, Tsuneoka M
    SF-KDM2A binds to ribosomal RNA gene promoter, reduces H4K20me3 level, and elevates ribosomal RNA transcription in breast cancer cells.
    Int J Oncol. 2017 Mar 10. doi: 10.3892/ijo.2017.3908.
    >> Share

  54. GIL EY, Jo UH, Jeong H, Whang YM, et al
    [Corrigendum] Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3900.
    >> Share

  55. ZHENG X, Wang C, Xing Y, Chen S, et al
    SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Int J Oncol. 2017;50:893-902.
    >> Share

    February 2017
  56. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
    Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
    >> Share

  57. LANGO-CHAVARRIA M, Chimal-Ramirez GK, Ruiz-Tachiquin ME, Espinoza-Sanchez NA, et al
    A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.
    Int J Oncol. 2017;50:432-440.
    >> Share

  58. GUERRIERO E, Sorice A, Capone F, Storti G, et al
    Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines.
    Int J Oncol. 2017;50:468-476.
    >> Share

    January 2017
  59. TRIANTAFILLU UL, Park S, Klaassen NL, Raddatz AD, et al
    Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
    Int J Oncol. 2017 Jan 30. doi: 10.3892/ijo.2017.3865.
    >> Share

  60. JIANG W, Li X, Li T, Wang H, et al
    Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
    Int J Oncol. 2017 Jan 24. doi: 10.3892/ijo.2017.3860.
    >> Share

    December 2016
  61. MAXWELL T, Chun SY, Lee KS, Kim S, et al
    The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
    Int J Oncol. 2016 Dec 29. doi: 10.3892/ijo.2016.3825.
    >> Share

  62. NAKAYAMA J, Ito E, Fujimoto J, Watanabe S, et al
    Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection.
    Int J Oncol. 2016 Dec 16. doi: 10.3892/ijo.2016.3809.
    >> Share

  63. PARK JH, Kim HK, Jung H, Kim KH, et al
    NecroX-5 prevents breast cancer metastasis by AKT inhibition via reducing intracellular calcium levels.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3789.
    >> Share

    November 2016
    miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
    Int J Oncol. 2016 Nov 7. doi: 10.3892/ijo.2016.3761.
    >> Share

  65. GOMULKIEWICZ A, Jablonska K, Pula B, Grzegrzolka J, et al
    Expression of metallothionein 3 in ductal breast cancer.
    Int J Oncol. 2016 Nov 4. doi: 10.3892/ijo.2016.3759.
    >> Share

    October 2016
  66. ZHOU H, Li J, Zhang Z, Ye R, et al
    RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Int J Oncol. 2016 Oct 5. doi: 10.3892/ijo.2016.3718.
    >> Share

    September 2016
  67. MEJIA-RANGEL J, Cordova E, Orozco L, Ventura-Gallegos JL, et al
    Pro-adhesive phenotype of normal endothelial cells responding to metastatic breast cancer cell conditioned medium is linked to NFkappaB-mediated transcriptomic regulation.
    Int J Oncol. 2016 Sep 26. doi: 10.3892/ijo.2016.3705.
    >> Share

  68. DING J, Guo C, Hu P, Chen J, et al
    CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3680.
    >> Share

  69. LIU ZG, Tang J, Chen Z, Zhang H, et al
    The novel mTORC1/2 dual inhibitor INK128 enhances radiosensitivity of breast cancer cell line MCF-7.
    Int J Oncol. 2016;49:1039-45.
    >> Share

  70. ZHAO Q, Zhao M, Parris AB, Xing Y, et al
    Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Int J Oncol. 2016;49:1203-10.
    >> Share

  71. PARK JH, Cho YY, Yoon SW, Park B, et al
    Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-kappaB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
    Int J Oncol. 2016;49:1230-40.
    >> Share

  72. GALLARDO M, Calaf GM
    Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines.
    Int J Oncol. 2016;49:1019-27.
    >> Share

  73. IBRAHIM T, Liverani C, Mercatali L, Sacanna E, et al
    [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.
    Int J Oncol. 2016;49:1260.
    >> Share

  74. CHA J, Roomi MW, Kalinovsky T, Niedzwiecki A, et al
    Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.
    Int J Oncol. 2016;49:895-902.
    >> Share

  75. PARK HJ, Kim MK, Choi KS, Jeong JW, et al
    Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
    Int J Oncol. 2016;49:934-42.
    >> Share

    August 2016
  76. MIYAHARA K, Kazama H, Kokuba H, Komatsu S, et al
    Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
    Int J Oncol. 2016 Aug 29. doi: 10.3892/ijo.2016.3673.
    >> Share

  77. HE DX, Zhang GY, Gu XT, Mao AQ, et al
    Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells.
    Int J Oncol. 2016 Aug 22. doi: 10.3892/ijo.2016.3665.
    >> Share

  78. KARIYA Y, Tatsuta T, Sugawara S, Kariya Y, et al
    RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells.
    Int J Oncol. 2016 Aug 11. doi: 10.3892/ijo.2016.3656.
    >> Share

  79. CHOI YJ, Heo K, Park HS, Yang KM, et al
    The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
    Int J Oncol. 2016 Aug 3. doi: 10.3892/ijo.2016.3647.
    >> Share

    July 2016
  80. XU H, Wu K, Tian Y, Liu Q, et al
    CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
    Int J Oncol. 2016 Jul 29. doi: 10.3892/ijo.2016.3639.
    >> Share

  81. SULAIMAN NB, Mohan CD, Basappa S, Pandey V, et al
    An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.
    Int J Oncol. 2016 Jul 6. doi: 10.3892/ijo.2016.3615.
    >> Share

    June 2016
  82. KIM B, Kim YC, Park B
    Pomolic acid inhibits metastasis of HER2 overexpressing breast cancer cells through inactivation of the ERK pathway.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3568.
    >> Share

    Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
    Int J Oncol. 2016 Jun 3. doi: 10.3892/ijo.2016.3558.
    >> Share

    May 2016
  84. PARK JH, Jang M, Tarhan YE, Katagiri T, et al
    Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
    Int J Oncol. 2016 May 27. doi: 10.3892/ijo.2016.3540.
    >> Share

  85. YAMAGUCHI M, Osuka S, Weitzmann MN, Shoji M, et al
    Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3538.
    >> Share

  86. MENG X, Hu B, Hossain MM, Chen G, et al
    ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3536.
    >> Share

  87. CHEN SY, Zheng XW, Cai JX, Zhang WP, et al
    Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
    Int J Oncol. 2016 May 17. doi: 10.3892/ijo.2016.3528.
    >> Share

  88. WOODMAN N, Pinder SE, Tajadura V, Le Bourhis X, et al
    Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3521.
    >> Share

  89. KWON YS, Lee KS, Chun SY, Jang TJ, et al
    Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3520.
    >> Share

  90. GARCIA EP, Tiscornia I, Libisch G, Trajtenberg F, et al
    MUC5B silencing reduces chemo-resistance of MCF-7 breast tumor cells and impairs maturation of dendritic cells.
    Int J Oncol. 2016;48:2113-23.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016